ARCHIVES

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012